Articles published by Benzinga
Decoding 15 Analyst Evaluations For Apellis Pharmaceuticals
March 27, 2024
Via Benzinga
Tickers
APLS
Expert Outlook: ResMed Through The Eyes Of 9 Analysts
March 27, 2024
Via Benzinga
The Most Important Catalyst For Merck's Stock In 2024 Could Be Sotatercept Launch, Analyst Says
March 27, 2024
Via Benzinga
Topics
Stocks
Exposures
US Equities
Tickers
MRK
Alibaba's Strategy Shift Aims for Turnaround with Enhanced Logistics and Share Buybacks, Earns Analyst Confidence
March 27, 2024
Via Benzinga
Topics
Initial Public Offering
Exposures
Securities Market
Tickers
BABA
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|